Nrg Therapeutics
About Nrg Therapeutics
NRG Therapeutics is a neuroscience-focused drug discovery company dedicated to developing disease-modifying therapies for neurodegenerative diseases. The company leverages breakthrough science in mitochondrial biology to identify new therapeutic targets, aiming to bring hope to the growing number of people worldwide living with these conditions.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series B | Sep 08, 2025 | $50.0M | SV Health Investors’ Dementia Discovery Fund, British Business Bank, AmberGroup_io +4 more |
Founders
No founder information available.
Investors
AmberGroup_io
Corporate Venture Capital
Brandon Capital
Venture Capital
British Business Bank
Development Bank
Criteria Bio Ventures
Venture Capital
Novartis Venture Fund
Corporate Venture Capital
Omega Funds
Venture Capital
SV Health Investors’ Dementia Discovery Fund
Venture Capital
Recent Mentions
🔬@NrgTherapeutics has raised £50 million in Series B funding. https://t.co/20Xc3IEggS The round was led by SV Health Investors’ Dementia Discovery Fund and joined by @BritishBBank, M Ventures, Novartis Venture Fund, Criteria Bio Ventures, Omega Funds and @brandoncapital.
NRG Therapeutics closes £50m Series B round https://t.co/TE8wzJ4iCt #UKtech
Similar Startups
Vigil Neuroscience
88% matchVigil Neuroscience is a biotechnology company focused on developing innovative therapies for neurode...
Therini Bio
88% matchTherini Bio is a biotechnology company focused on developing innovative therapeutics for neurodegene...
Epigenic Therapeutics
88% matchA clinical-stage innovative drug development company focused on next-generation gene modulation ther...
Kriya Therapeutics
88% matchKriya Therapeutics is a biopharmaceutical company focused on developing innovative gene therapies to...